IMAC Holdings, Inc. Appoints Dr. Matthew Schwartz and Dr. Peter Beitsch to Board of Directors
July 11, 2024 09:21 ET
|
IMAC Holdings, Inc.
Golden, CO, July 11, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (NASDAQ: BACK) (the “Company” or “IMAC”), a leading innovator in proteomics research and technology, announced the appointment of...
IMAC Holdings Announces Leadership Succession
May 24, 2024 09:00 ET
|
IMAC Holdings, Inc.
Faith Zaslavsky appointed as CEO to succeed Jeff Ervin FRANKLIN, Tenn., May 24, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC”) today announced leadership transitions to the...
IMAC Holdings Acquires Assets of Theralink to Continue Precision Medicine Business
May 07, 2024 08:30 ET
|
IMAC Holdings, Inc.
FRANKLIN, Tenn., May 07, 2024 (GLOBE NEWSWIRE) -- On May 1, 2024, as previously announced, pursuant to that certain Settlement and Release Agreement, by and between IMAC Holdings, Inc. (NASDAQ:...
IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements
September 27, 2023 16:30 ET
|
IMAC Holdings, Inc.
Franklin, TN, Sept. 27, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”) today announced that it has received notice from The Nasdaq Stock Market LLC informing...
IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split
September 07, 2023 12:45 ET
|
IMAC Holdings, Inc.
Franklin, TN, Sept. 07, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”) today announced a reverse stock split of its outstanding shares of common stock at a...
IMAC Holdings Announces $4.3 Million Private Placement of Convertible Preferred Stock and Warrants Priced at the Market
July 26, 2023 09:25 ET
|
IMAC Holdings, Inc.
Franklin, Tennessee, July 26, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in...
IMAC Holdings Annual Meeting of Shareholders Reminder
June 28, 2023 16:30 ET
|
IMAC Holdings, Inc.
Shareholders are reminded to vote their shares prior to the proxy voting deadline of 7:00pm on July 4, 2023 FRANKLIN, Tenn., June 28, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK)...
Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company
May 23, 2023 09:43 ET
|
IMAC Holdings, Inc.
Theralink’s patented technology is helping to solve a significant problem in cancer treatment by providing game changing technology that can predict FDA-approved drugs that may be effective in each...
IMAC Holdings Reports Year End 2022 Financial Results and Corporate Update
March 31, 2023 20:00 ET
|
IMAC Holdings, Inc.
Revenue increased 14% annually driven by greater adoption of medical treatments. BRENTWOOD, Tenn., March 31, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), a...
IMAC Holdings and Brain Scientific Announce a Strategic Merger to Create Synergistic End-To-End Neurological Solution
March 20, 2023 07:30 ET
|
IMAC Holdings, Inc.
Combined company will provide total solutions, from diagnosis to treatment, for patients with neurological disorders including Parkinson’s, Alzheimer's, and stroke. BRENTWOOD, Tenn. and LAKEWOOD...